skip to Main Content

News

Latest News, Announcements, and Press Releases

30Apr 15

Codexis to Hold 2015 First Quarter Conference Call on May 7

REDWOOD CITY, Calif., April 30, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it will report first quarter 2015 financial results after market close…
read more
03Mar 15

Codexis to Present at ROTH Conference

REDWOOD CITY, Calif., March 3, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that President and CEO John Nicols and Senior Vice President and CFO…
read more
03Mar 15

Codexis Reports 2014 Fourth Quarter and Full Year Results

Achieves First Milestone Payment from GSK Introduces 2015 financial guidance — Conference call begins at 4:30 p.m. Eastern time today — REDWOOD CITY, Calif., March 3, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts…
read more
02Feb 15

Codexis to Present at BIO CEO & Investor Conference

REDWOOD CITY, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that President and CEO John Nicols and Senior Vice President and CFO…
read more
07Nov 14

Merck and Codexis receive 2014 Thomas Edison Patent Award

Merck Research Laboratories, Merck & Co., and Codexis inventors Chris Savile, Emily Mundorff, Jeffrey C. Moore, Paul N. Devine, and Jacob M. Janey received a 2014 Thomas Edison Patent Award together for the groundbreaking Transaminase Biocatalysts invention, which was developed…
read more

Since 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.

Unlock the power of proteins® with Codexis

Back To Top
Close search
Search